RxDoctor Payments DataLook up a doctor →

Briviact: payments to doctors

Payments that named Briviact as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$7.1M
Providers
16,438
Transactions
143,825
Average per transaction
$49

The per-transaction average — $49 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 16,438 providers the average total is $432, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
UCB, Inc.$6,876,94096.9%
UCB SA$192,5062.7%
UCB Biosciences Inc.$26,1140.4%
UCB GmbH$4100.0%
← All drugs & devices